Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Latest Articles
Submit an article Journal homepage
19
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Response to “assessment of risk of ALS conferred by the GGGGCC hexanucleotide expansion in C9orf72 among first-degree relatives of patients with ALS carrying the repeat expansion”

Laynie Dratch1 Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA
,
Daniel D. Kinnamon2 Division of Human Genetics, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA
,
Elizabeth A. Harrington3 Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA
,
Jill Goldman3 Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA
,
Jamie C. Fong4 Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA;5 Department of Neurology, Memory and Aging Center, University of California—San Francisco, San Francisco, CA, USA
,
Tara Jones6 Neurosciences Department, Cedars-Sinai Medical Center, Los Angeles, CA, USA
,
Wendy R. Uhlmann7 Division of Genetic Medicine, Department of Internal Medicine; Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA, and
&
Jennifer Roggenbuck2 Division of Human Genetics, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA;8 Department of Neurology, The Ohio State University Wexner Medical Center, Columbus, OH, USACorrespondence[email protected]
 show all
Received 24 Mar 2024, Accepted 27 May 2024, Published online: 20 Jun 2024
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Disclosure statement

The authors DDK, EAH, JG, and WRU report there are no competing interests to declare. LD has consulted for Sano Genetics, Passage Bio, and Biogen. TJ holds shares in Invitae and Myriad, commercial genetic testing labs. JR has consulted for Biogen and Ionis. JCF has consulted for Alector, Inc.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 478.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.